Nutrineal Pd4 (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Nutrineal Pd4 is an amino acid mixture used in clinical nutrition to support patients with increased metabolic demand or impaired protein intake.

• Critical illness: helps maintain nitrogen balance and supports tissue repair.
• Post‑surgical recovery: contributes to wound healing and muscle preservation.
• Severe malnutrition: provides essential amino acids when oral intake is insufficient.
• Long‑term parenteral nutrition: serves as a component of total parenteral nutrition regimens.
• Metabolic disorders: assists in managing conditions with altered amino‑acid metabolism.

• The formulation supplies a balanced profile of essential and non‑essential amino acids that are directly incorporated into protein synthesis pathways. By increasing plasma amino‑acid concentrations, it stimulates mTOR signaling, promotes nitrogen retention, and supports cellular repair processes without requiring metabolic conversion of precursors.

Nutrineal Pd4 may be associated with adverse reactions typical of parenteral amino‑acid solutions.

Common Side Effects

• Injection site pain: mild discomfort at the infusion site.
• Hypernatremia: transient increase in serum sodium.
• Metabolic alkalosis: shift in acid‑base balance.
• Elevated liver enzymes: mild, reversible changes.
• Hypersensitivity rash: skin redness or itching.
• Fever: low‑grade temperature rise.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Acute renal failure: sudden loss of kidney function.
• Severe hyperammonemia: dangerous rise in blood ammonia levels.
• Thromboembolic events: clot formation in veins or arteries.
• Sepsis: systemic infection linked to catheter use.
• Persistent electrolyte disturbances: prolonged imbalance of potassium, calcium, or magnesium.

When using Nutrineal Pd4, clinicians should consider several safety measures.

• Monitor renal function: assess creatinine and urine output regularly.
• Check electrolyte status: watch for sodium, potassium, and calcium shifts.
• Assess liver enzymes: detect potential hepatic stress.
• Observe for signs of infection: especially at catheter sites.
• Evaluate acid‑base balance: watch for metabolic alkalosis or acidosis.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Nutrineal Pd4 can interact with other agents administered intravenously or affecting amino‑acid metabolism.

Major Interactions (Avoid)

• High‑dose corticosteroids: may exacerbate hyperglycaemia and protein catabolism.
• Loop diuretics: increase risk of electrolyte depletion.
• Amino‑acid antagonists (e.g., valproate): can alter plasma amino‑acid levels.

Moderate Interactions (Monitor Closely)

• Insulin therapy: may require dose adjustment due to altered glucose metabolism.
• Other parenteral nutrition components: balance total nitrogen and caloric load.
• Anticoagulants: monitor coagulation parameters if central lines are used.